• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Akers Biosciences Inc

AKR:PZ

Ticker Delisted

Snapshot for Akers Biosciences Inc (AKR)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for AKR

No chart data available.
  • AKR:PZ
  • 1M
  • 1Y
0.00
Interactive AKR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3950
Est. PEG Ratio -
Market Cap (M GBP) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKR

Akers Biosciences, Inc. develops diagnostic kits. The Company produces kits that screen blood, urine, or saliva to rapidly diagnose HIV, hepatitis B, lyme disease, sexually transmitted diseases, mononucleosis, rheumatoid arthritis, hepatitis C, malaria and the presence of alcohol and several drugs. The kits can be used in clinics, hospitals, and doctors' offices.

Raymond F Akers JrChairman/President/CEO/Co-FounderThomas J KnoxCo-Chairman
Gary RauchTreasurer/Controller
More Company Profile & Key Executives for AKR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • AKR News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil